Prostate Adenocarcinoma Clinical Trials in Los Angeles, California
8 studies are recruiting for prostate adenocarcinoma in Los Angeles, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
This phase III trial compares stereotactic body radiation therapy (SBRT), (five treatments over two weeks using a higher dose per treatment) to usual radiation therapy (20 to 45 treatments over 4 to 9 weeks) for the treatment of high-risk prostate cancer. SBRT uses special equipment to position a p…
- Stage
- Phase 3
- Ages
- 18 and older
- Site
- Cedars-Sinai Medical Center, Los Angeles, California
- Locations
- 413 in total
- Run by
- NRG Oncology
-
Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy, URO-PRO Trial
This phase II randomized control trial assesses the effect of Urolithin A (Uro-A) supplementation compared to placebo in men with biopsy-confirmed prostate cancer undergoing radical prostatectomy (RP) progressive disease. A total of 90 men will be accrued and randomized 1:1 to receive a 1000 mg dai…
- Stage
- Phase 2
- Ages
- 18 and older
- Site
- Cedars-Sinai Medical Center, Los Angeles, California
- Locations
- 5 in total
- Run by
- National Cancer Institute (NCI)
-
High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma
This phase II trial investigates the effect of high dose-rate brachytherapy and stereotactic body radiotherapy in treating patients with prostate adenocarcinoma. Brachytherapy, also known as internal radiation therapy, uses radioactive material placed directly into or near a tumor to kill tumor cel…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University of California at Los Angeles / Jonsson Comprehensive Cancer Center, Los Angeles, California
- Run by
- Jonsson Comprehensive Cancer Center
-
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
This phase III trial tests two questions by two separate comparisons of therapies. The first question is whether enhanced therapy (apalutamide in combination with abiraterone + prednisone) added to standard of care (prostate radiation therapy and short term androgen deprivation) is more effective c…
- Stage
- Phase 3
- Ages
- 18 and older
- Site
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California
- Locations
- 341 in total
- Run by
- ECOG-ACRIN Cancer Research Group
-
Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes
This is a Phase 2, randomized two-armed, multi-site study of 138 patients with metastatic castrate sensitive prostate adenocarcinoma. Patients will be randomized 1:1 to receive the fasting mimicking diet, or usual diet. All patients will receive standard of care treatment for their prostate cancer.…
- Stage
- Phase 2
- Ages
- Any age
- Site
- Cedars-Sinai Medical Center, Los Angeles, California
- Locations
- 3 in total
- Run by
- Stephen Freedland
-
A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer
To determine the effects of exercise therapy on molecular, radiologic, and pathologic nimbosus hallmarks versus usual care control in men on Active Surveillance for localized prostate cancer.
- Stage
- Phase 2
- Ages
- 18 and older
- Site
- University of California, Los Angeles (Data and Specimen Analysis Only), Los Angeles, California
- Locations
- 10 in total
- Run by
- City of Hope Medical Center
-
Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE Trial
This phase II trial evaluates apalutamide in combination with image-guided stereotactic body radiation therapy (SBRT) for the treatment of patients with prostate cancer. Prostate cancer usually needs the hormone testosterone to grow. Apalutamide is a hormone therapy that blocks the effect of testos…
- Stage
- Phase 2
- Ages
- 18 and older
- Site
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California
- Run by
- Jonsson Comprehensive Cancer Center
-
Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer
This clinical trial tests the effect of focal radiation therapy, high dose rate-brachytherapy (HDR-BT), in treating patients with prostate cancer. Prostate cancer is the most diagnosed cancer in men and there are many treatments available, including surgery and radiation therapy. Although surgery a…
- Stage
- Not phased
- Ages
- 40 and older
- Site
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California
- Run by
- Jonsson Comprehensive Cancer Center
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.